[2015-04-28] Equipment Procurement Tender Notice for the Personalized Cell Therapy Technology Development and Industrialization Project Based on Regional Central Laboratories
(2015-04-28) Shenzhen Beike Biotechnology Co., Ltd. is issuing a tender for the procurement of equipment for the Personalized Cell Therapy Technology Development and……
[2015-03-05] Equipment Procurement Tender Notice for the Personalized Cell Therapy Technology Development and Industrialization Project Based on Regional Central Laboratories
(2015-03-05) Shenzhen Beike Biotechnology Co., Ltd. is issuing a tender for the procurement of equipment for the Personalized Cell Therapy Technology Development and……
ALS, SCI Research Shows Astrocytes’ Importance in Treatment
New research on the importance of astrocytes in Amyotrophic Lateral Sclerosis (ALS) and spinal cord injury (SCI) treatments was published recently showing that these cells give incredible support to……
Dr. Sun Sheds Light on Business Deals Behind Beike Biotechnology
As an intern at Beike Biotechnology I have been eager to see what opportunities and challenges are presented for an international company based in China, especially one in such a……
The Immunotherapy Revolution Is Under Way
New Wave Of Cancer Drugs 14 million new cancer cases a year 8.2 million cancer deaths in 2012. These shocking statistics show that cancer is a huge problem facing modern……
“e-Dura,” Another Spinal Cord Injury Breakthrough
2014 was undeniably a great year for spinal cord injury breakthroughs, and it seems 2015 is off to a strong start as well. These new SCI breakthroughs are truly ushering……
In Duchenne Muscular Dystrophy Stem Cells Found to be Faulty
Overview In a new study by Stanford University Medical Center mice with a form of Duchenne Muscular Dystrophy (DMD)underwent progressive muscle degeneration and accumulated connective tissue as they……
Source Concord Acquires Beike Biotechnology Shares
On the evening of December 22, the Source Concord Cell Gene Engineering Co., Ltd. (Source Concord) announced a 13 percent (118.7 million yuan) acquisition of shares held by Dr. Xiang……
[2014-12-05 · BK-ZB04] Equipment Procurement Tender Notice for the Personalized Cell Therapy Technology Development and Industrialization Project Based on Regional Central Laboratories
(2014-12-05 · BK-ZB04) Shenzhen Beike Biotechnology Co., Ltd. is issuing a tender for the procurement of equipment for the Personalized Cell Therapy Technology Development and……
[2014-12-05 · BK-ZB08] Equipment Procurement Tender Notice for the Personalized Cell Therapy Technology Development and Industrialization Project Based on Regional Central Laboratories
(2014-12-05 · BK-ZB08) Shenzhen Beike Biotechnology Co., Ltd. is issuing a tender for the procurement of equipment for the Personalized Cell Therapy Technology Development and……
[2014-10-20] Equipment Procurement Tender Notice for the Personalized Cell Therapy Technology Development and Industrialization Project Based on Regional Central Laboratories
(2014-10-20) Shenzhen Beike Biotechnology Co., Ltd. is issuing a tender for the procurement of equipment for the Personalized Cell Therapy Technology Development and……
Altor BioScience and Shenzhen Beike Biotechnology Announce License Agreement for Immunotherapeutic ALT-803 in China
MIRAMAR, Fla. & SHENZHEN, China, Sep 10, 2014 (BUSINESS WIRE) — Altor BioScience Corporation (Altor), a U.S.-based developer of novel cancer immunotherapies, and Shenzhen Beike Biotechnology Co.……